IP Library Patent Application 16444294
Patent Application
App. No. 16/444,294

Methods and Systems for Low Power/Low Cost Hematocrit Measurement for Blood Glucose Meter

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/444,294
Abstract

Systems and methods for hematocrit measurement are provided. The present disclosure provides systems and methods for a low power and low-cost utilization of a microprocessor to capture hematocrit measurements for a blood glucose meter. The systems and methods include an electronic meter for performing a diagnostic test on a sample applied to a test strip inserted. The electronic meter can include a low cost low power microcontroller for capturing the hematocrit measurements. The microcontroller includes trans-impedance amplifiers (TIAs) configured to read a current over the test strip to generate a response waveform, an analog-to-digital (ADC) converter to convert the response waveform into a digital value, a peak detector circuit configured to capture peak current magnitude of the response waveform, and a peak detector circuit configured to capture a peak current time

Claims (41)

1 . A system for diagnostic testing comprising:

a test strip; and

an electronic meter for performing a diagnostic test on a sample applied to the test strip inserted therein, the electronic meter comprising:

a housing having a test port for receiving the test strip;

trans-impedance amplifiers (TIAs) configured to read a current over the test strip to generate a response waveform;

an analog-to-digital (ADC) converter to convert the response waveform into a digital value;

a peak detector circuit configured to capture peak current magnitude of the response waveform; and

a peak detector circuit configured to capture a peak current time.

2 . The system of claim 1 , wherein the reading the current over the test strip includes measuring a response current to an excitation voltage.

3 . The system of claim 1 , wherein the TIAs generate the response waveform from the current.

4 . The system of claim 3 , wherein the peak detector circuit captures the peak current time based on the captured peak current magnitude from the peak detector circuit and the response waveform from the TIAs.

5 . The system of claim 3 , wherein an excitation signal is applied to the blood sample such that the response to the excitation signal is analyzed to determine a glucose concentration in the blood sample.

6 . The system of claim 1 , wherein the TIAs convert current to a differential voltage waveform for analog-to-digital conversion by the ADC.

7 . The system of claim 9 , wherein a microprocessor is further programmed to detect when the sample is applied to the test strip.

8 . The system of claim 12 , wherein a microprocessor is further programmed to display a glucose concentration.

9 . A diagnostic testing device comprising:

a housing having a test port for receiving a test strip;

trans-impedance amplifiers (TIAs) configured to read a current over the test strip to generate a response waveform;

a peak detector circuit configured to capture peak current magnitude of the response waveform;

a peak detector circuit configured to capture a peak current time; and

an analog-to-digital (ADC) converter to convert the response waveform and the peak current magnitude into a digital value.

10 . The device of claim 9 , wherein the reading the current over the test strip includes measuring a response current to an excitation voltage.

11 . The device of claim 9 , wherein the TIAs generate the response waveform from the current.

12 . The device of claim 11 , wherein the peak detector circuit captures the peak current time based on the captured peak current magnitude from the peak detector circuit and the response waveform from the TIAs.

13 . The device of claim 11 , wherein an excitation signal is applied to the blood sample such that the response to the excitation signal is analyzed to determine a glucose concentration in the blood sample.

14 . The device of claim 13 , wherein the TIAs convert current to a differential voltage waveform for analog-to-digital conversion by the ADC.

15 . The device of claim 13 , wherein a microprocessor is further programmed to detect when the sample is applied to the test strip.

16 . The device of claim 15 , wherein a microprocessor is further programmed to display a glucose concentration.

17 . A method for a low cost and low power hematocrit testing, the method comprising:

applying a voltage to a sample on a test strip;

measuring, by trans-impedance amplifiers (TIAs), a current through the sample;

processing, by the TIAs, the current and outputting a voltage response waveform to an analog digital converter (ADC);

processing, by the peak detector, the voltage response waveform and outputting a peak current to the ADC; and

calculating and displaying hematocrit compensated glucose results based on the values received by the ADC.

18 . The method of claim 17 , further comprises:

outputting, by the TIAs, the voltage response waveform to a peak comparator; and

outputting, by the peak detector, the peak current to the peak comparator.

19 . The method of claim 18 , further comprises processing, by the peak comparator, the voltage response waveform and the peak current and outputting a peak time value.

20 . The method of claim 19 , calculating the compensated glucose results comprises:

calculating an HTC value based on the peak current and peak time value; and

adjusting a glucose measurement to the hematocrit compensated glucose results.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Aug 29, 2025
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: TRIVIDIA HEALTH, INC.; TRIVIDIA HEALTHCARE SYSTEMS, LLC
Reel/Frame 072752/0646 →
SECURITY INTEREST Recorded Jan 30, 2020
From: TRIVIDIA HEALTH, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 051675/0876 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2019
From: LEONE, STEVEN V.; MODZELEWSKI, BRENT E.
To: TRIVIDIA HEALTH, INC.
Reel/Frame 049968/0832 →